Centogene
Matthias Berg is a Senior Data Scientist at CENTOGENE since September 2020, specializing in the analysis of targeted and untargeted metabolomics experiments on iPSC cellular disease models, with a focus on drug discovery for Gaucher disease and target identification for Niemann-Pick type C disease in collaboration with Evotec and InSilico Medicine. Prior experience includes a postdoctoral position at Helmholtz-Zentrum Berlin from 2017 to 2019 and a doctoral program in Theoretical Chemistry at Freie Universität Berlin from 2012 to 2017, where research centered on weak interactions in fluorine-containing compounds. Matthias Berg also completed community service at Marianne Cohn Schule, supporting students and teachers at a special needs education center. Educational qualifications include a Dr. rer. nat in Theoretical Chemistry, as well as M.Sc. and B.Sc. degrees in Chemistry from Freie Universität Berlin.
This person is not in the org chart
Centogene
2 followers
Centogene BV is a Germany-based company engaged in the rare disease market. It focuses on transforming clinical, genetic and biochemical data into medical solutions for patients, physicians and pharmaceutical companies. The Company provides the full spectrum of methods and technology for human genetics analysis. It develops a rare disease platform based on its real-world data repository with over 2.0 billion weighted data points from over 450, 000 patients representing around 115 different, which includes epidemiologic, phenotypic and genetic data that reflects a global population, as well as a biobank of patients' blood samples. In addition, it is active in the research and development products for human genetics. The Company operates in Germany and the United States.